Boditech Med, Inc. engages in the provision of in-vitro diagnostics analyzers and reagents. Its products include cardiac, tumor, diabetes, hormone, infection, and rheumatoid arthritics tests. The company was founded on November 13, 1998 and is headquartered in Chuncheon-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company